QIAO
41.0550 EUR
+2.17%
Today
+2.01%
1D
Last seen at Tue, 24 Feb 2026 19:14:00 GMT+3
Market is closed
Sun
Closed
Mon
10:01 AM ~ 6:30 PM
Tue
10:01 AM ~ 6:30 PM
Wed
10:01 AM ~ 6:30 PM
Thu
10:01 AM ~ 6:30 PM
Fri
10:01 AM ~ 6:30 PM
Sat
Closed
Performance
1 Day
+ 2.01 %
1 Week
- 6.34 %
1 Month
- 12.46 %
3 Month
+ 1.04 %
6 Month
+ 1.04 %
1 Year
+ 1.04 %
Information
Name
QIAGEN N.V. ( DE )
Currency
EUR
Standard Leverage
1X
Market Cap
9.75B
Avg Daily Volume
1.05M
52 Week High
51.88 EUR
52 Week Low
37.63 EUR
Trading Hours
See hours
Business Summary
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Top News
Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions
finance.yahoo.com
8mo ago
Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research
finance.yahoo.com
9mo ago
UPDATE 1-Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports
reuters.com
11mo ago
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
